Delivery Order SPE2DB22D2206-SPE2DB24FJX93

Award Date 8/22/24
Potential Completion Date 8/23/24
Potential Value $117K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $21,371.16 firm-fixed-price contract is for the supply of 4,565,371,847 units of the specialty medication STELARA (45 mg/0.5 mL syringe). The award has an ultimate completion date of August 8, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued at up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The $11,177.46 firm fixed-price contract is for the supply of STELARA 45 MG/0.5 ML syringes. The order has an ultimate completion date of September 19, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) by various defense and civilian agencies to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Stelara 90 mg/mL syringes. The award, valued at $7,831.94, was made through a Delivery Order contract mechanism with a Firm Fixed Price pricing structure. The contract has an ultimate completion date of August 28, 2024 and was not set aside for any specific business category. AmerisourceBergen, through its Corporate Office...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of STELARA 90 MG/ML syringes. The award, valued at $66,179.03, has a firm fixed price and an ultimate completion date of August 20, 2024. The contract is not set aside for any special business type. AmerisourceBergen, a major pharmaceutical distributor, has been awarded several federal contracts and Indefinite Delivery Contracts (IDCs) to provide a wide range of medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $14,247.44, is for the supply of 4565634369 - STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product. The award is a firm fixed-price delivery order with an ultimate completion date of August 30, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple Indefinite Delivery Contracts (IDCs) by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $51,746.35 Delivery Order contract is for the supply of Stelara 90 mg/ml syringes, a specialty medication used for various medical treatments. The contract has a firm fixed price and an ultimate completion date of September 22, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $4,366.28 firm-fixed-price delivery order is for the supply of STELARA 45 MG/0.5 ML syringes, a specialty pharmaceutical product. The contract has a completion date of July 19, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with the DLA and other agencies, valued up to $999,999,999, to provide...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $7,154.84 firm-fixed-price contract is for the supply of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product. The contract has an ultimate completion date of August 15, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of essential medical commodities to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $14,646.35 delivery order contract is for the supply of Stelara 90 mg/mL syringes, a specialty medication. The contract is a firm fixed-price arrangement with a completion date of September 25, 2024. Amerisourcebergen is a for-profit organization that has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and other federal...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $16,849.01, is for the supply of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product. The contract has a firm fixed-price pricing type and an ultimate completion date of August 21, 2024. AmerisourceBergen, one of the largest pharmaceutical distributors in the United States, has been...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FJX93
    Delivery Order

This is a $116,764.08 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of Stelara 90 mg/ml syringes, a specialty pharmaceutical product. The award has an ultimate completion date of August 23, 2024 and is a firm fixed-price contract. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and Indefinite Delivery Contracts (IDCs) by defense and civilian agencies to provide a wide range of essential medical commodities, including prescription drugs, vaccines, and medical supplies. These contracts support the healthcare needs of military personnel, veterans, and other federal beneficiaries across various locations and healthcare settings.

Generated 11/21/24, 9:34 AM